These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10026781)

  • 1. Vasopressin receptors. A historical survey.
    Jard S
    Adv Exp Med Biol; 1998; 449():1-13. PubMed ID: 10026781
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocytosis of the vasopressin receptor.
    Kumar R
    Semin Nephrol; 1994 Jul; 14(4):357-67. PubMed ID: 7938951
    [No Abstract]   [Full Text] [Related]  

  • 3. From vasopressin receptor to water channel: intracellular traffic, constraint and by-pass.
    Laycock JF; Hanoune J
    J Endocrinol; 1998 Dec; 159(3):361-72. PubMed ID: 9834453
    [No Abstract]   [Full Text] [Related]  

  • 4. Potent antagonists of vasopressin antidiuretic activity that lack the beta,beta-cyclopentamethylene-beta-mercaptopropionic acid substitution at position 1.
    Yim NC; Moore ML; Huffman WF; Bryan HG; Chang HL; Kinter LB; Edwards R; Stassen FL; Schmidt D; Heckman G
    J Med Chem; 1986 Dec; 29(12):2425-6. PubMed ID: 2946863
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vasopressin: cellular and molecular aspects of its antidiuretic effect].
    Ivanova LN
    Vestn Ross Akad Med Nauk; 1999; (3):40-5. PubMed ID: 10222831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpeptide antagonists for vasopressin receptors. Pharmacology of SR 121463A, a new potent and highly selective V2 receptor antagonist.
    Serradeil-Le Gal C
    Adv Exp Med Biol; 1998; 449():427-38. PubMed ID: 10026834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin action in the mammalian cerebral cortex.
    Brinton RD; Yamazaki RS; Chen Q; Son M
    Adv Exp Med Biol; 1998; 449():211-3. PubMed ID: 10026807
    [No Abstract]   [Full Text] [Related]  

  • 8. Receptors to vasopressin and other hormones in the mammalian kidney.
    Morel F; Imbert-Teboul M; Chabardès D
    Kidney Int; 1987 Feb; 31(2):512-20. PubMed ID: 3031358
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence that monensin inhibits vasopressin-stimulated water flow at an early step in the receptor-adenylate cyclase sequence.
    Franki N; Mosenkis B; Hays RM
    Biol Cell; 1989; 66(1-2):19-22. PubMed ID: 2478241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of action of vasopressin and vasopressin antagonists.
    Jard S
    Kidney Int Suppl; 1988 Oct; 26():S38-42. PubMed ID: 2974096
    [No Abstract]   [Full Text] [Related]  

  • 11. The development of vasopressin antagonists.
    Sawyer WH; Manning M
    Fed Proc; 1984 Jan; 43(1):87-90. PubMed ID: 6317468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of vasopressin action in the renal collecting duct.
    Knepper MA; Nielsen S; Chou CL; DiGiovanni SR
    Semin Nephrol; 1994 Jul; 14(4):302-21. PubMed ID: 7938946
    [No Abstract]   [Full Text] [Related]  

  • 13. [Vasopressin].
    Ota K; Kimura T
    Nihon Rinsho; 2000 Jan; 58 Suppl 1():80-4. PubMed ID: 11026240
    [No Abstract]   [Full Text] [Related]  

  • 14. Vasopressin signaling in kidney cells.
    Ausiello DA; Skorecki KL; Verkman AS; Bonventre JV
    Kidney Int; 1987 Feb; 31(2):521-9. PubMed ID: 2951552
    [No Abstract]   [Full Text] [Related]  

  • 15. V1b receptors: new probes for therapy.
    Arban R
    Endocrinology; 2007 Sep; 148(9):4133-5. PubMed ID: 17699680
    [No Abstract]   [Full Text] [Related]  

  • 16. Vasopressin and disorders of water balance: the physiology and pathophysiology of vasopressin.
    Ball SG
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):417-31. PubMed ID: 17761027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical and experimental pharmacology of vasopressin agonists and antagonists].
    Rudichenko VM
    Eksp Klin Farmakol; 1994; 57(2):68-73. PubMed ID: 8205056
    [No Abstract]   [Full Text] [Related]  

  • 18. Voles, vasopressin, and the ethics of framing.
    McKaughan DJ; Elliott KC
    Science; 2012 Dec; 338(6112):1285. PubMed ID: 23224537
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of vasopressin antagonists in human diseases.
    Thibonnier M
    Kidney Int Suppl; 1988 Oct; 26():S48-51. PubMed ID: 2974097
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxytocin and vasopressin: social neuropeptides with complex neuromodulatory functions.
    Benarroch EE
    Neurology; 2013 Apr; 80(16):1521-8. PubMed ID: 23589638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.